Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARR: Ramipril and Rosiglitazone in Atherosclerosis
NCT00140647Phase 3Completed
- Start
- Jul 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ramipril, rosiglitazone in atherosclerosis. Started Jul 2001; status: completed.
02
Drugs
ramiprilrosiglitazone
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00140647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140647.